Guided Therapeutics, FDA resolve PMA issues over cervical scanner; Device manufacturer Accelent loses $ in Q2;

@FierceMedDev: St. Jude's recalled Riata leads get slapped again. News | Follow @FierceMedDev

 @MarkHFierce: BG Medicine has pulled a 510(k) filing for a cardiac disease test. Shockingly, investors weren't happy. Story | Follow @MarkHFierce

 @DamianFierce: Despite losing $7M on three recalls, CareFusion posted an income boost for fiscal Q4. News  | Follow @DamianFierce

> Guided Therapeutics says it has hashed out a plan with FDA officials to move forward with a PMA submission for its scanner device designed to screen for cervical diseases that lead to cancer. Progress on the noninvasive device comes after regulators issued a "not-approvable" letter on Jan. 20, 2012.  Release

> Accelent, a manufacturing outsourcer for cardiology, endoscopy and orthopedic medical device companies, generated $130.2 million in net sales during its 2012 second quarter and lost $5.6 million. Release

> Actuated Medical gained FDA clearance for a portion of its TubeClear system, which is used to unclog feeding and decompression tubes. Story

> GeNO gained FDA clearance to market its new inhaled nitric oxide delivery system for ventilator use. Release

> Accelr8, a diagnostics/medical instrument company, is bringing in Steve Reichling as its new chief financial officer. He is a veteran executive who previously worked at Roche Tissue Diagnostics and Ventana Medical Systems, among other places. Release

> A Covidien executive sounds off on "the continuum of care," via MedCity News. Video

Biotech News

 @FierceBiotech: Nanomaterial propels animals' heart attack-damaged hearts to repair themselves. Article | Follow @FierceBiotech

 @JohnCFierce: Sen. Gillibrand wants to create a $200M marketing fund for biotechs. From petri dish to marketplace? Report | Follow @JohnCFierce

 @RyanMFierce: Orbimed has backed Intercept Pharma in a $30M C round with lead drug for primary biliary cirrhosis. Release | Follow @RyanMFierce

> Forest makes nice with shareholders ahead of Icahn showdown. Article

> Intercept Pharma snags $30M round amid PhIII for liver-disease drug. News

> Industry Voices: Designing Probiotics - You Get What You Select For. Column

> FDA OKs Talon's drug for rare leukemia. More

Pharma News

 @FiercePharma: Special reports this week: Top 11 Fastest-Growing Generics Companies | Top 10 Drug Advertising Spends -- Q1 2012.  | Follow @FiercePharma

> New statins study sorts out diabetes risks. More

> Roche blockbuster Avastin does well as brain tumor therapy. Story

> Forest board yields in investor lawsuits. Article

> Generic cream price spikes have experts scratching their heads. Report

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.